Genprex to Participate in Next Generation Lipid-Based Nanoparticles Delivery Summit

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...

Related Keywords

Boston ,Massachusetts ,United States ,Texas ,Rodney Varner ,Rajesh Shinde ,Astrazeneca Tagrisso ,Hemant Kumar ,Genprex Inc ,Merck Co Keytruda ,Linkedin ,Panel Participant ,Drug Administration ,Manufacturing Technology Operations ,Delivery Technology Landscape ,Exchange Commission ,Facebook ,Company Manufacturing Leads Selected ,Thought Leaders ,Discuss Advances ,Lipid Nanoparticle Delivery Systems ,Translating Innovative Gene Therapy Drug Targets ,Chief Manufacturing ,Novel Lipid Chemistry ,Lipid Based Delivery Technology ,Chief Executive Officer ,Nanoparticle Delivery System ,Fast Track Designation ,Private Securities Litigation Reform Act ,Annual Report ,Genprex ,Nc ,